medl is a health tech startup based in Trinidad and Tobago. A social impact enterprise, medl is backed by the IDB Lab and Microsoft for Startups and has been recognised by PAHO/WHO as a Social Innovation in Health for 2021. Selected by the Financial Times x Seedstars as a winning startup out of 4500+ global entrants innovating in the UNs Sustainable Development Goals, medl solves the problem of prescription non-adherence. 1 in 2 prescriptions globally is never filled, leading massive increases in healthcare costs and reduced quality of life for millions of people around the world.
medl’s aim is to work with Patient Reported Outcomes and Smart Data to dramatically reduce the cost of Stage 3 – 4 Drug Trials, leading to increased health equity and access to targeted therapeutics for underrepresented populations in the developing world.
|TT-built app Medl gets US$120,000 in 'cloud credit' from Microsoft||https://newsday.co.tt/2021/07/22/tt-built-app-medl-gets-us120000-microsoft-grant/|
|FINANCIAL TIMES AND SEEDSTARS ANNOUNCE 6 GLOBAL WINNERS OF FTXSDG CHALLENGE||https://irishtechnews.ie/financial-times-winners-of-ftxsdg-challenge/|
|Medl cops technology award||https://trinidadexpress.com/business/local/medl-cops-technology-award/article_e858afbc-5d34-11ec-9f66-b7b191473689.html|
|Find out the results of the Call for Social Innovations in Health 2021!||https://www.facebook.com/sihilac/posts/3181554838756002|